Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03JRG
|
|||
Former ID |
DIB018015
|
|||
Drug Name |
VU0364739
|
|||
Synonyms |
VU 0364739
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coagulation defect [ICD-11: 3B10.0; ICD-10: I80-I82] | Clinical trial | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C26H27FN4O2
|
|||
Canonical SMILES |
C1CN(CCC12C(=O)NCN2C3=CC(=CC=C3)F)CCNC(=O)C4=CC5=CC=CC=C5C=C4
|
|||
InChI |
1S/C26H27FN4O2/c27-22-6-3-7-23(17-22)31-18-29-25(33)26(31)10-13-30(14-11-26)15-12-28-24(32)21-9-8-19-4-1-2-5-20(19)16-21/h1-9,16-17H,10-15,18H2,(H,28,32)(H,29,33)
|
|||
InChIKey |
MSTXJJGAXXJCBY-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phospholipase D2 (PLD2) | Target Info | Inhibitor | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5287). | |||
REF 2 | Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor. J Med Chem. 2010 Sep 23;53(18):6706-19. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.